M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
about
Use of lectin-functionalized particles for oral immunotherapyEnhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexesBioavailability of silver nanoparticles and ions: from a chemical and biochemical perspectiveIntestinal M cells: the fallible sentinels?Preparation of alginate coated chitosan microparticles for vaccine deliveryUncovering Potential Applications of Cyanobacteria and Algal Metabolites in Biology, Agriculture and Medicine: Current Status and Future Prospects.Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells.Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes.Distribution patterns of carbohydrates in murine glycocalyxImproving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys?Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.Starch microparticles as vaccine adjuvant.Mammalian gut immunity.Oral Norovirus Infection Is Blocked in Mice Lacking Peyer's Patches and Mature M Cells.Managing diabetes with nanomedicine: challenges and opportunitiesM-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens.Moving forward: a mucosal vaccine against group A streptococcus.Bioadhesive delivery systems for mucosal vaccine delivery.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Microbial lectins and their prospective mitogenic potential.Metal ions in sugar binding, sugar specificity and structural stability of Spatholobus parviflorus seed lectin.Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Murine norovirus transcytosis across an in vitro polarized murine intestinal epithelial monolayer is mediated by M-like cells.Oral delivery of particulate prostate cancer vaccine: in vitro and in vivo evaluation.Identification of adhesin-receptor interactions driving bacterial translocation through M cells.Lectin-mediated cytotoxicity and specificity of 5-fluorouracil conjugated with peanut agglutinin (5-Fu-PNA) in vitro.Freeze-dried targeted mannosylated selenium-loaded nanoliposomes: development and evaluation.Phospholipid vesicle-bound lysozyme to enhance permeability in human intestinal cells.Carbohydrate binding and unfolding of Spatholobus parviflorus lectin: fluorescence and circular dichroism spectroscopic study.Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer's patches.Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy.Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.Patterning of microspheres and microbubbles in an acoustic tweezersParticulate transepithelial drug carriers: barriers and functional polymers
P2860
Q26849550-4F3988C0-8A8C-4DD8-8C7E-54B909CADBBFQ27309096-879A2A20-120F-47EA-9D4C-44CA3C871CDBQ28387987-4C593186-C86A-481C-AA6D-2BEACB0786DEQ30050457-863AC25D-FE93-4B41-9EB9-6398259A6C36Q33385532-252553FD-420E-4CEC-9715-89598FD69337Q33600275-998F9191-A415-4F84-9B62-ECF768FD332AQ33743895-01E20BB7-7C56-4EC2-93FB-F152D20F0BF4Q35287340-C09F7E2A-8992-4E5B-81D7-53F9EB2C05E0Q35644348-A0A7A66C-3F81-43CE-A109-FC967892C603Q35863373-8D195AAF-46D8-4190-8CBC-E9917FA918FEQ36316646-2DFC8D0E-7E18-4A27-98E2-A35FE4AB2F74Q36316814-E0671EB5-19DC-46AC-88FD-A2D1B2756D7EQ36468059-0D452738-BACB-4C11-9B72-2E46921BBA4AQ36481488-F09D35E5-2B39-46DA-8C17-AB9B0135F165Q36574654-56B53BCB-3D9B-489A-98BB-760D954C275DQ37256573-A0C3A2BC-1758-4F30-9530-FD2B59C5F057Q37503248-DDD38C91-B05B-41A3-9050-65ADE6873B3EQ37805519-2BB64FFC-ACFB-4BB0-8873-AF5B0E3D9937Q38041190-0DA2D1F6-EB64-4F16-BCB2-04F654A09E05Q38065207-9FAA65BA-1C6D-458B-AA62-C0A6309D9345Q38315710-3A6CE035-AD2B-4719-8218-4C16463A86A3Q38689914-741DA3BF-1C17-4C66-AA63-521522C9D8C4Q38862706-A6323DAF-872D-4615-8413-3C39D13CB9DBQ39094216-B9744455-CC28-4FB6-859A-81B96F02C9E4Q39403174-474194DD-CE41-4427-AE07-CC82809436B9Q39887350-4BE0A388-779F-497D-B8AA-37C7066741CBQ40392040-EC231CF5-C3F5-404F-A008-3DD62718CFDAQ42574200-19F0B480-9A68-42E2-8713-D992380972BDQ43622154-FDDE1425-2855-4037-9198-E150C83FA330Q44486508-FF9CDAD1-883B-4635-B2CA-748400BA4613Q45963439-0B976E6C-0F7E-4BB3-928D-C4E514A9D5D1Q52612978-F4FF7BF9-61C3-4641-9F58-386166E46685Q55223335-1D8D00AF-71EE-4C61-8C34-FF8295CB2961Q56890785-75A5E0FF-01D4-49A0-8EFF-A2BC6190D049Q58385253-C3154750-C558-43EC-AE51-C3E2DEBB37A8
P2860
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
@ast
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
@en
type
label
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
@ast
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
@en
prefLabel
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
@ast
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
@en
P2093
P1476
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.
@en
P2093
Barry H Hirst
M Ann Clark
Mark A Jepson
P304
P356
10.1016/J.ADDR.2003.10.018
P407
P577
2004-03-01T00:00:00Z